This video was not produced by NetworkPharma.tv but has been included within the library because it is directly relevant to individuals who work in medcomms and is here with permission from its owner.

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

For this edition of their webinar series “Keeping it real”, Dr Mark Larkin, Founder and CEO of Vitaccess, and Sam Llewellyn, Senior Consultant, presented a webinar on adding safety reporting to create continuous pre- to post-approval longitudinal digital RWE studies. Joining them was special guest Esther Daemen, Senior Clinical Research, Quality, Regulatory, and GDPR Consultant in the pharma and biotech industries. They looked at how the use of digital tools means that longitudinal RWE studies can be considered as adaptive registries, with a powerful range of both pre- and post-approval use cases.

Recorded as a live webinar, 26 January 2022, by Vitaccess and is included here with their permission.

Mark’s LinkedIn page is at https://www.linkedin.com/in/marklarkin-vitaccess/

Sam’s LinkedIn page is at https://www.linkedin.com/in/samuelllewellyn/

Esther’s LinkedIn page is at https://www.linkedin.com/in/esther-daemen-6b273816/

You can find out more about Vitaccess at https://vitaccess.com

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

We are building a library of free webcasts and other video content for the global MedComms Community and others at http://www.networkpharma.tv and we’d welcome your suggestions for new content.